Recent Publications
David Karasik: Standardization of bone morphometry and mineral density assessments in zebrafish and other small laboratory fishes using x-ray radiography and micro-computed tomography (J Bone Miner Res .)
Zebrafish and other small laboratory fishes are emerging as important animal models for investigating human skeletal development and diseases. In recent years, there has been a notable increase in research publications employing x-ray radiography and micro-computed tomography to analyze the skeletal structures of these animals. However, evaluating bone morphology and mineral density in small laboratory fish poses unique challenges compared to well-established small rodent models. The varied approaches to image acquisition, analysis, and reporting across studies have led to substantial obstacles in interpreting and comparing research findings. This article addresses the urgent need for standardized reporting of parameters and methodologies related to image acquisition and analysis, as well as the adoption of harmonized nomenclature.
Fadel Bahouth: Cardiac Amyloidosis Screening and Management in Heart Failure with Preserved Ejection Fraction patients: an International Survey (Am J Cardiol .)
There is an uncertainty regarding the need for screening of HFpEF patients for cardiac amyloidosis (CA) globally. CA remains a disease with very heterogeneous management, particularly in the screening and diagnostic workup. The HF community should aim to educate on CA and improve access to disease-modifying therapy.
Michal Carmiel: Updated Results from the Retrospective CREST Study on the Safety and Effectiveness of 8-Week Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis (Adv Ther . )
This brief report presents updated findings from the previously published CREST study evaluating the safety and effectiveness of 8-week glecaprevir/pibrentasvir (GLE/PIB) in treatment-naïve patients with chronic hepatitis C virus (HCV) infection and compensated cirrhosis. The current study includes an additional 51 patients, presents effectiveness data stratified by additional comorbidities and comedications, and offers insights into healthcare resource utilization.
Helana Jeries: IgG4-related Breast Disease: Review of the Literature (Rambam Maimonides Med J . )
IgG4-related disease (IgG4-RD) is a rare illness with inflammatory and fibrotic changes in affected organs such as pancreas, thyroid, salivary or lacrimal glands, and retroperitoneal space; rarely other organs may be involved. IgG4-related breast disease (IgG4-BD) is very rare and generally presents as a lump or mastitis. IgG4-BD as a presenting feature of IgG4-RD is extremely rare. Hence, this paper reviews the known (n=48) IgG-BD cases reported in the literature to date.
Avi Benov: Association between the number of individuals injured in a traumatic event and posttraumatic stress disorder among hospitalized trauma patients (J Trauma Stress . )
Posttraumatic stress disorder (PTSD) often occurs following mass casualty events, yet the connection between the number of individuals injured in an event and PTSD risk in smaller-scale events (i.e., involving one or several injured persons) remains unclear. We conducted a registries-based study cross-referencing three databases across the continuum of care for military trauma patients hospitalized for traumatic injuries.
Naim Shehadeh: Safety, Growth and Development After Dapagliflozin or Saxagliptin in Children With Type 2 Diabetes (T2NOW Follow-Up) (J Clin Endocrinol Metab . )
The T2NOW trial of dapagliflozin or saxagliptin versus placebo in pediatric patients with type 2 diabetes (T2D) demonstrated promising efficacy data for dapagliflozin and did not raise any safety concerns over 52 weeks.
Objective: Assess long-term effects of prior dapagliflozin/saxagliptin administration on safety, growth and development.
Rawi Hazzan: Sex Differences in Colonoscopy Indications and Findings: Results from a Large Multicenter Database (J Womens Health (Larchmt) .)
Sex-based differences are common among diseases. We aimed to investigate the differences in colonoscopy indications and its findings between males and females.
Shirin Hamed Azzam, Salem Kassem, Jerdev Michael: Langerhans cell histiocytosis of the orbit: pediatric case series (Can J Ophthalmol . )
Describes the clinical, imaging characteristics, and treatment of pediatric orbital Langerhans cell histiocytosis (LCH).
Michael Edelstein: Long Covid: a global health issue - a prospective, cohort study set in four continents (BMJ Glob Health .)
A proportion of people develop Long Covid after acute COVID-19, but with most studies concentrated in high-income countries (HICs), the global burden is largely unknown. Our study aims to characterise long-term COVID-19 sequelae in populations globally and compare the prevalence of reported symptoms in HICs and low-income and middle-income countries (LMICs).
Naaem Simaan: Development and Validation of a Clinical Score to Predict Epilepsy After Cerebral Venous Thrombosis (JAMA Neurol .)
One of 10 patients develop epilepsy in the late phase after cerebral venous thrombosis (CVT) diagnosis but predicting the individual risk is difficult.
Objective: To develop and externally validate a prognostic score to estimate the individual risk of post-CVT epilepsy.
Rawi Hazzan: Increased Risk of Non-Hodgkin Lymphoma in Autoimmune Hepatitis: A Large Retrospective Cohort Study (J Clin Med . )
Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease caused by an autoimmune attack on hepatocytes. The first-line treatment for AIH comprises two core components: glucocorticoids and thiopurine analog inhibitors and mycophenolate mofetil (MMF). Numerous studies have suggested an increased risk for lymphoma among patients with either rheumatoid arthritis or inflammatory bowel disease (IBD) who are treated with azathioprine/6-mercaptopurine (6-MP). The relative risk of non-Hodgkin lymphoma (NHL) among autoimmune hepatitis patients treated with these immunosuppressive drugs remains unclear. We aimed at investigating the risk of NHL across a large retrospective AIH cohort after a long-term follow-up.
Yaara Artsi: Advancing Clinical Practice: The Potential of Multimodal Technology in Modern Medicine (J Clin Med .)
Multimodal technology is poised to revolutionize clinical practice by integrating artificial intelligence with traditional diagnostic modalities. This evolution traces its roots from Hippocrates' humoral theory to the use of sophisticated AI-driven platforms that synthesize data across multiple sensory channels. The interplay between historical medical practices and modern technology challenges conventional patient-clinician interactions and redefines diagnostic accuracy. Highlighting applications from neurology to radiology, the potential of multimodal technology emerges, suggesting a future where AI not only supports but enhances human sensory inputs in medical diagnostics. This shift invites the medical community to navigate the ethical, practical, and technological changes reshaping the landscape of clinical medicine.
Basel H Nasser, Jimmy E Jadaon, Nibal Awad-Khamaisy, Luna Abo Lfoul, Israel Hendler: Novel risk factors associated with retained placenta after vaginal birth (Int J Gynaecol Obstet . )
Objective: To evaluate maternal and obstetric risk factors associated with retained placenta following singleton live vaginal births.
Aladdin Mohana, Murad AbdelRaziq, Imad Abu El-Naaj: Transoral approach for hilo-parenchymal submandibular stones: outcomes and predictors of success (Oral Surg Oral Med Oral Pathol Oral Radiol . )
Evaluates the efficacy and safety of transoral surgical management for complex submandibular gland (SMG) stones.
Ory Wiesel, Alaa Awad, Lina Abzah: The Potential Benefit of a Novel Urine Biosensor Platform for Lung Cancer Detection in the Decision-Making Process: From the Bench to the Bedside (J Clin Med . )
Lung cancer is the leading cause of cancer-related mortality worldwide. Lung cancer screening and early detection resulted in a decrease in cancer-specific mortality; however, it introduced additional dilemmas and adherence barriers for patients and providers. Methods: Innovations such as biomolecular diagnosis and biosensor-based technology improve the detection and stratification of high-risk patients and might assist in overcoming adherence barriers, hence providing new horizons for better selection of screened populations.